
Karen Christman, professor in the Department of Bioengineering at UC San Diego, led the development of Ventrigel, a hydrogel to repair heart tissue after heart attacks.
Ventrix, a University of California San Diego spin-off company, has successfully conducted a first-in-human, FDA-approved Phase 1 clinical trial of an injectable hydrogel that aims to repair damage and restore cardiac function in heart failure patients who previously suffered a heart attack.
The trial is the first to test a hydrogel designed to repair cardiac tissue. It is also the first to test a hydrogel made from the natural scaffolding of cardiac muscle tissue, also known as extracellular matrix, or ECM. This is significant because ECM hydrogels have been shown in preclinical studies to potentially be effective for other conditions, such as poor blood circulation due to peripheral artery disease. The trial showed that the hydrogel, known as VentriGel, can be safely injected via catheter into patients who had suffered a heart attack in the past 2 to 36 months.
“Although the study was designed to evaluate safety and feasibility and not designed to show whether VentriGel effectively helps improve heart function, we observed some improvements in patients,” said Karen Christman, the paper’s senior author and a professor of bioengineering in the Jacobs School of Engineering and the Institute of Engineering in Medicine at UC San Diego. “For example, patients could walk longer distances. We also observed signs of improving heart function in patients who experienced a heart attack more than one year prior to treatment.”
Researchers from Ventrix, led by Christman, report their findings in the Sept. 11 issue of the Journal of the American College of Cardiology: Basic to Translational Science. Dr. Jay Traverse from the Minneapolis Heart Institute Foundation at Abbott Northwestern Hospital was the lead clinical investigator.
There are an estimated 785,000 new heart attack cases in the United States each year, with no established treatment for repairing the resulting damage to cardiac tissue. After a heart attack, scar tissue develops, which diminishes muscle function and leads to heart failure. This is where VentriGel comes in. Once injected in damaged cardiac muscle, VentriGel forms a scaffold that acts as a reparative environment where healthy cells migrate, leading to increases in cardiac muscle, less scar tissue, and improvements in heart function.
VentriGel was invented by Christman and her team, then licensed from UC San Diego and developed by Ventrix, Inc, which was cofounded by CEO Adam Kinsey and Christman.
VentriGel is made from cardiac connective tissue taken from pigs, which is stripped of heart muscle cells through a cleansing process. It is then freeze-dried and milled into powder form, and then liquefied into a fluid that can be easily injected into heart muscle in a minimally invasive procedure that does not require surgery. Once it hits body temperature, the liquid turns into a semi-solid, porous gel.
The Phase 1 trial evaluated the gel in 15 patients who sustained moderate damage in the left ventricle chamber of the heart following a heart attack. Each patient received up to 18 injections of VentriGel into the damaged region via catheter. Researchers followed the patients for six months after treatment. All patients completed the full follow-up.
Twelve of the 15 patients were men. All 15 were experiencing mild to moderate heart failure following a heart attack. Half had suffered a heart attack within the past year.
Patients took a six-minute walking test as well as a heart function assessment and a heart health questionnaire before the injections. They retook the tests three and six months later. In addition, patients underwent an MRI at three and six months after the procedures.
Ventrix is now gearing up for a Phase 2 clinical trial that will expand on this successful first-in-human study. They are planning a larger, randomized trial that will evaluate how effectively VentriGel can improve cardiac function and quality of life for patients experiencing heart failure.
Learn more: FDA Phase 1 Trial Shows Hydrogel to Repair Heart Is Safe to Inject in Humans—A First
The Latest on: Heart repair
via Google News
The Latest on: Heart repair
- Listening to music linked to significant reduction in anxiety/pain after major heart surgeryon January 25, 2021 at 3:34 pm
Listening to music is linked to a significant reduction in anxiety and pain after major heart surgery, finds a pooled data analysis of the available evidence, published in the online journal Open ...
- ‘Like my heart was trying to tear through my rib cage.’ Idahoans describe long COVIDon January 25, 2021 at 3:19 pm
BOISE (Idaho Statesman) — Hearing loss. Out of work for months. Eleven trips to the emergency room. Heart racing in the middle of the night. Lung tests, heart tests, brain scans and blood tests. Aches ...
- Prosthetic Heart Valves Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2021 - 2027on January 25, 2021 at 9:45 am
Jan (Heraldkeepers) -- Global Prosthetic Heart Valves Industry The Prosthetic heart valve market is expected to grow significantly at a CAGR ...
- Column: Surgery now or knee replacement by age 20. Sandburg’s Keegan Carey choose the surgery, and is closer to ‘my dream.’on January 25, 2021 at 8:55 am
Sandburg senior outside hitter Keegan Carey talked with Tony Baranek about a long-needed knee surgery, her thoughts about leadership and hopes for a return to the court.
- Transcatheter Heart Valve Replacement Market Size – Detailed Analysis of Current Industry Figures with Forecasts Growth By 2025on January 25, 2021 at 6:40 am
Jan (Market Insight Reports) -- Selbyville, Delaware, Market Study Report LLC has added a new report on Transcatheter Heart Valve Replacement ...
- This month’s spotlight highlights Automotive Collision Repair, Automotive Technologyon January 24, 2021 at 9:12 pm
The ongoing pandemic has impacted the way schools in the county proceed with their normal daily activities. This means that it is uncertain when schools will be able to welcome visitors back into ...
- US America's Cup challenger: heart still beats after capsizeon January 23, 2021 at 3:14 pm
American Magic’s race boat Patriot might have been battered and broken when it capsized at speed during the America’s Cup challenger series in Auckland, but skipper Terry Hutchinson says its proud ...
- “Heart the Wall” spreads love in Grand Ledgeon January 22, 2021 at 4:46 pm
Several hearts are hanging on the wall outside of Mac Dowell’s Fireplace in Grand Ledge. It’s for the “Heart the Wall” campaign.
- On the cutting edge of heart surgeryon January 21, 2021 at 9:41 pm
Havasu Regional Medical Center is one of the leaders in the state when it comes to offering a variety of treatments for aortic stenosis — an affliction of the aortic ...
- Structural Heart Devices Market Overview With Detailed Analysis, Competitive Landscape, Forecast To 2027on January 20, 2021 at 7:18 am
AVAILABLE ON DEMAND The global structural heart devices market was valued at 6 006 million in 2015 and is expected to reach 12 076 million by 2022 supported by a CAGR of 10 5 during the forecast ...
via Bing News